Neurogene Inc [NASDAQ: NGNE] price surged by 1.21 percent to reach at $0.25.
A sum of 133926 shares traded at recent session while its average daily volume was at 219.80K shares. Neurogene Inc shares reached a high of $21.733 and dropped to a low of $20.09 until finishing in the latest session at $20.99.
The one-year NGNE stock forecast points to a potential upside of 64.42. The average equity rating for NGNE stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Neurogene Inc [NGNE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NGNE shares is $59.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NGNE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Neurogene Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2025. The new note on the price target was released on May 16, 2025, representing the official price target for Neurogene Inc stock. Previously, the target price had yet another raise to $65, while BMO Capital Markets analysts kept a Outperform rating on NGNE stock.
The Price to Book ratio for the last quarter was 1.17, with the Price to Cash per share for the same quarter was set at 17.13.
NGNE Stock Performance Analysis:
Neurogene Inc [NGNE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by 0.00. With this latest performance, NGNE shares dropped by -32.33% in over the last four-week period, additionally plugging by 12.01% over the last 6 months – not to mention a drop of -8.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NGNE stock in for the last two-week period is set at 37.49, with the RSI for the last a single of trading hit 2.39, and the three-weeks RSI is set at 2.67 for Neurogene Inc [NGNE]. The present Moving Average for the last 50 days of trading for this stock 25.64, while it was recorded at 20.53 for the last single week of trading, and 19.63 for the last 200 days.
Neurogene Inc (NGNE) Capital Structure & Debt Analysis
According to recent financial data for Neurogene Inc. ( NGNE), the Return on Equity (ROE) stands at -42.25%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -37.67%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Neurogene Inc’s Return on Invested Capital (ROIC) is -31.22%, showcasing its effectiveness in deploying capital for earnings.
Neurogene Inc (NGNE) Efficiency & Liquidity Metrics
Based on Neurogene Inc’s (NGNE) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.
Neurogene Inc (NGNE) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Neurogene Inc. (NGNE) effectively leverages its workforce, generating an average of -$795607.48 per employee. The company’s liquidity position is robust, with a Current Ratio of 18.37% and a Quick Ratio of 18.37%, indicating strong ability to cover short-term liabilities.
NGNE Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NGNE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Neurogene Inc go to -11.90%.
Neurogene Inc [NGNE] Institutonal Ownership Details
There are presently around $99.66%, or 108.97%% of NGNE stock, in the hands of institutional investors. The top three institutional holders of NGNE stocks are: BLACKROCK INC. with ownership of 1.39 million shares, which is approximately 8.2325%. ECOR1 CAPITAL, LLC, holding 1.27 million shares of the stock with an approximate value of $$46.26 million in NGNE stocks shares; and ECOR1 CAPITAL, LLC, currently with $$46.13 million in NGNE stock with ownership which is approximately 7.4833%.
